
DermTech DMTK
Annual report 2023
added 02-29-2024
DermTech ROA Ratio 2011-2025 | DMTK
Annual ROA Ratio DermTech
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -82.74 | -57.74 | -31.55 | -50.51 | 7.59 | 0.58 | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 7.59 | -82.74 | -35.73 |
Quarterly ROA Ratio DermTech
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -66.35 | -67.27 | -60.99 | -41.08 | -48.54 | -41.16 | -33.68 | -19.34 | -71.61 | -116.44 | -162.51 | -156.82 | -188.27 | -167.43 | -135.43 | -52.48 | -43.59 | 4.62 | 24.89 | 24.1 | 15.38 | -1.21 | -1.23 | 126.87 | 126.7 | 126.53 | 126.55 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 126.87 | -188.27 | -33.33 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | ||
|
Brainsway Ltd.
BWAY
|
-8.53 | $ 19.37 | - | $ 99.4 M | ||
|
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 21.18 | - | $ 228 M | ||
|
Co-Diagnostics
CODX
|
-37.07 | $ 0.24 | - | $ 7.04 M | ||
|
Castle Biosciences
CSTL
|
3.43 | $ 39.4 | - | $ 1.09 B | ||
|
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | ||
|
Danaher Corporation
DHR
|
5.03 | $ 230.32 | - | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.04 | - | $ 285 M | ||
|
BioNano Genomics
BNGO
|
-146.1 | $ 1.52 | - | $ 1.93 M | ||
|
Exact Sciences Corporation
EXAS
|
-14.58 | $ 101.57 | - | $ 18.8 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
8.64 | $ 67.57 | - | $ 26.1 B | ||
|
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
-3.5 | $ 26.72 | - | $ 808 M | ||
|
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
-40.76 | $ 19.48 | - | $ 1.05 B | ||
|
Celcuity
CELC
|
-45.6 | $ 102.25 | - | $ 4.03 B | ||
|
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
-58.14 | $ 3.2 | - | $ 102 K | ||
|
Myriad Genetics
MYGN
|
-12.39 | $ 6.48 | - | $ 587 M | ||
|
ENDRA Life Sciences
NDRA
|
-258.47 | $ 5.08 | - | $ 2.73 M | ||
|
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | ||
|
Neogen Corporation
NEOG
|
-31.71 | $ 7.13 | - | $ 1.55 B | ||
|
IQVIA Holdings
IQV
|
5.1 | $ 226.92 | - | $ 41.1 B | ||
|
National Research Corporation
NRC
|
25.3 | $ 18.66 | - | $ 458 M | ||
|
Guardant Health
GH
|
-29.37 | $ 102.98 | - | $ 12.6 B | ||
|
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | ||
|
Personalis
PSNL
|
-30.08 | $ 8.14 | - | $ 482 M | ||
|
Quidel Corporation
QDEL
|
43.3 | $ 29.3 | - | $ 1.23 B | ||
|
QIAGEN N.V.
QGEN
|
1.47 | $ 45.37 | - | $ 10.1 B | ||
|
RadNet
RDNT
|
0.08 | $ 73.15 | - | $ 5.34 B | ||
|
Illumina
ILMN
|
-19.4 | $ 134.95 | - | $ 21.5 B | ||
|
Charles River Laboratories International
CRL
|
0.29 | $ 203.66 | - | $ 10.5 B | ||
|
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 175.94 | - | $ 19.5 B | ||
|
Biodesix
BDSX
|
-44.15 | $ 6.82 | - | $ 884 M | ||
|
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 253.89 | - | $ 21.3 B | ||
|
Thermo Fisher Scientific
TMO
|
6.51 | $ 580.74 | - | $ 222 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 182.84 | - | $ 15.1 B | ||
|
IDEXX Laboratories
IDXX
|
26.96 | $ 688.48 | - | $ 56.8 B | ||
|
Lantheus Holdings
LNTH
|
15.78 | $ 66.71 | - | $ 4.62 B | ||
|
Mettler-Toledo International
MTD
|
26.64 | $ 1 420.1 | - | $ 30.1 B |